Great News for Pennsylvania: mAbs At Home is expanding to Pennsylvania, starting on Monday with the Philadelphia area. Pennsylvania now has at-home, no-cost COVID Monoclonal Antibody treatments available! Go to mabsathome.com to qualify and sch…lnkd.in/dEVnMGG7

I agree 💯. No one has saved more lives during this pandemic than Chaim M Lebovits - there will be a movie one day mark my words…

Netflix #HasidicHero

If you tested positive or have been exposed to #COVID19 you may be eligible to get #monoclonalantibodies treatment in the comfort of your home at no cost to you. mabsathome.com Rockland County DOH, nychealthy, Westchester County Health Department, Orange County Gov't Regeneron GSK Survivor Corps

FREE at home Monoclonal Antibodies!!! R/t and save a life.

booradley Rockland County DOH nychealthy Westchester County Health Department Orange County Gov't Regeneron GSK Survivor Corps NY, NJ, PA, MD, FL, NV and expanding

RCT of convalescent plasma (CP) for COVID-19 from Pittsburg shows reduced mortality. They achieved statistical significance in a small study by the innovation of using local high titer plasma and giving 2 units on day 1 of hospitalization Journal of Clinical Investigation pubmed.ncbi.nlm.nih.gov/34788233/

LTCmABs.com 833-LTC-MABS [email protected] lnkd.in/eb3aPr5c

Shmuel gets it done! TIME IS RUNNING OUT 🏃‍♂️ 🏃‍♀️ lnkd.in/ekhrFV_U

Today the U.S. FDA both limited and expanded the scope of COIVD-19 convalescent plasma (CCP) in the USA. It limited use to the immunosuppressed and expanded to outpatients. I agree with the change to the CP Emergency Use Authorization - here are my reasons. fda.gov/media/141477/d…

Arturo Casadevall U.S. FDA Highest & best use for expanded EUA is getting plasma to nursing home patients, the most vulnerable; & resident in a medical setting conducive to safe transfusions COVID PLASMA mapped this in May 2020: covidplasmasavealife.com/nursing-home-p… Michael Joyner Shmuel Shoham Dorry Segev Diana Berrent Güthe

Early Outpatient Treatment for Covid-19 with Convalescent Plasma | NEJM nejm.org/doi/full/10.10…

Convalescent plasma is a relatively inexpensive treatment for Covid-19, but its benefits among outpatients with recent symptom onset are unclear. New research findings are summarized in a short video. nej.md/3OB6Wkx

Contact Your US Congressman & Demand that Congress Pass the COVID Bill Shortage of COVID Antibody Treatments There is currently a severe shortage of COVID monoclonal antibody treatments. The Federal government, who controls the entire country's supply o…lnkd.in/gjvBy8Ga

In this OpEd we credit the U.S. FDA actions in making COVID-19 convalescent plasma available with saving thousands of lives in the USA. In a pandemic noted by many foibles this was a decision done right, which provides a good precedent for 'the next one'. thehill.com/opinion/health…